Barcelona Area, Spain
Partner & CEO Market Access at OMAKASE Consulting S.L.
Pharmaceuticals
Education
IESE Business School - University of Navarra 2005 — 2006
PDD, Business Administration
King's College London, U. of London 1990 — 1994
PhD, BIOTECHNOLOGY/MOLECULAR BIOLOGY
University of Warwick 1989 — 1990
MSc, BIOTECHNOLOGY
Universidad del País Vasco/Euskal Herriko Unibertsitatea 1983 — 1988
BSc(Hons.), MICROBIOLOGY
Experience
OMAKASE Consulting S.L. May 2015 - Present
Boehringer Ingelheim November 2012 - January 2015
Regulatory, Pricing and Reimbursement and Market Access Consultancy May 2008 - January 2013
AMGEN S.A. December 2005 - April 2008
AMGEN S.A. June 2004 - December 2005
AMGEN LTD 1999 - June 2004
GLAXO SMITHKLINE January 1994 - January 1999
Skills
Sales Effectiveness, Hardware Diagnostics, Reimbursement, Regulatory Submissions, Pharmacoeconomics, Pharmaceuticals, HEOR, Biopharmaceuticals, Pricing, Regulatory Affairs, Business Strategy, Clinical Development, Health Economics, R&D, Therapeutic areas, Market Access, Biotechnology, Pharmacovigilance, Strategic Planning, Healthcare, Diabetes, Cross-functional Team..., Clinical Trials, Drug Development, Clinical Research, Pharmaceutical Industry, Pharmaceutical Sales, Product Development, Outcomes Research, Diagnostics, Medical Devices, Oncology, Lifesciences, Therapeutic Areas